Literature DB >> 16965947

Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women.

Manfred Hartard1, Christine Kleinmond, Michael Wiseman, Ernst R Weissenbacher, Dieter Felsenberg, Reinhold G Erben.   

Abstract

The aim of this cross-sectional analysis was to examine the skeletal effects of low-dose monophasic oral contraceptive (OC) use in a cohort of 248 young Caucasian women aged 18-24 years. Areal bone mineral density (BMD) of the femoral neck and lumbar spine was evaluated by dual-energy X-ray absorptiometry. Volumetric BMD, bone mineral content (BMC), and bone geometry were assessed in the tibia by peripheral quantitative computed tomography (pQCT). The women were allocated into ever or never OC users, and also into 5 different OC groups according to duration and time of initiation of OC use. Women with >2 years of OC use and OC initiation within 3 years after menarche were characterized by 10% lower femoral neck areal BMD (P<0.001), 5% lower spine areal BMD (not significant, P=0.101), 7% lower distal tibial total BMC (P<0.05), and 6% lower total BMC at the tibial shaft (P<0.05) relative to never users. In addition, women who had ever used OCs had lower bone mass at the femoral neck and tibial shaft, despite similar age, height, weight, BMI, hours of exercise, and calcium intake compared with never users. At the tibial shaft, OC users showed reduced total cross-sectional area, and increased cortical BMD. In conclusion, our data suggest that OC use is associated with a detrimental effect on bone mass in young women, and provide further insight into the pathophysiological mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965947     DOI: 10.1016/j.bone.2006.08.001

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  19 in total

Review 1.  Oral contraceptive use and bone.

Authors:  Shuying Wei; Tania Winzenberg; Laura L Laslett; Alison Venn; Graeme Jones
Journal:  Curr Osteoporos Rep       Date:  2011-03       Impact factor: 5.096

2.  Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation.

Authors:  Delia Scholes; Rebecca A Hubbard; Laura E Ichikawa; Andrea Z LaCroix; Leslie Spangler; Jeannette M Beasley; Susan Reed; Susan M Ott
Journal:  J Clin Endocrinol Metab       Date:  2011-07-13       Impact factor: 5.958

3.  Site-specific differences in bone mineral density in black and white premenopausal South African women.

Authors:  S Chantler; K Dickie; J H Goedecke; N S Levitt; E V Lambert; J Evans; Y Joffe; L K Micklesfield
Journal:  Osteoporos Int       Date:  2011-03-03       Impact factor: 4.507

Review 4.  Update on hormonal contraception and bone density.

Authors:  Michelle M Isley; Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

5.  Oral contraceptive use and bone mass in women aged 26-36 years.

Authors:  S Wei; G Jones; R Thomson; T Dwyer; A Venn
Journal:  Osteoporos Int       Date:  2010-02-27       Impact factor: 4.507

6.  Severe postpartum osteoporosis with increased PTHrP during lactation in a patient after total thyroidectomy and parathyroidectomy.

Authors:  E Segal; I Hochberg; Y Weisman; S Ish-Shalom
Journal:  Osteoporos Int       Date:  2011-01-18       Impact factor: 4.507

7.  Oral contraceptive use and bone density in adolescent and young adult women.

Authors:  Delia Scholes; Laura Ichikawa; Andrea Z LaCroix; Leslie Spangler; Jeannette M Beasley; Susan Reed; Susan M Ott
Journal:  Contraception       Date:  2010-01       Impact factor: 3.375

8.  Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.

Authors:  Mags E Beksinska; Immo Kleinschmidt; Jenni A Smit; Timothy M M Farley; Helen V Rees
Journal:  Contraception       Date:  2009-03-19       Impact factor: 3.375

9.  Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.

Authors:  Mags E Beksinska; Immo Kleinschmidt; Jenni A Smit; Timothy M M Farley
Journal:  Contraception       Date:  2009-01-17       Impact factor: 3.375

10.  Osteopenia and osteoporosis among 16-65 year old women attending outpatient clinics.

Authors:  Rowshan Ara Begum; Liaquat Ali; Jesmin Akter; Osamu Takahashi; Tsuguya Fukui; Mahbubur Rahman
Journal:  J Community Health       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.